AmphiStar
Universiteit Gent

AmphiStar

Biotech
Biotech
Biotech
Biotech

AmphiStar offers a portfolio of locally sourced biosurfactants to companies seeking to develop sustainable, performant & affordable products

AmphiStar offers a portfolio of locally produced microbial biosurfactants to companies seeking to develop sustainable, performant & affordable products with surfactants as important performance ingredients. AmphiStars’ surfactants are not linked to fossil feedstocks, direct land use or deforestation and offer a sustainable alternative to companies in the home- and personal care sector, but also to other sectors applying surfactants such as the agro-, food-, feed-, industrials,… sectors. The surfactant market is huge (20 million tonnes produced each year) which are mainly produced from fossil- and palm feedstocks through classic chemistry. AmphiStar offers a game changing technology using biobased (waste) feedstocks and biological and mild processing to produce a range of sustainable biosurfactants.

AmphiStar is the first company to produce and offer sophorolipid products which are 100% sourced from biobased waste- and side streams to the market. This is AmphiStars first go-to-market product, which was recently showcased in the “Too Good to Waste” Ecover consumer cleaning products (https://www.ecover.com/action/too-good-to-waste/). These first products will be followed by other microbial biosurfactants from our product portfolio. As such AmphiStar aims to make biosurfactants mainstream.

No items found.
Sofie Baeten

Sofie Baeten

Managing Partner Qbic II & III, (Co-)founder Qbic II & III

This company is aligned with the following SDGs

Responsible consumption and production
Responsible consumption and production
moveUP
Qbic II
HealthTech
HealthTech
HealthTech
HealthTech

moveUP

moveUP develops personalized remote digital care for patients undergoing surgery and other interventions.

AZ Maria Middelares
VUB
Obulytix
Qbic III
HealthTech
HealthTech
HealthTech
HealthTech

Obulytix

Obulytix develops the next generation of enzyme-based antibiotics inspired by nature.

Universiteit Gent
MRM Health
Qbic II
Biotech
Biotech
Biotech
Biotech

MRM Health

MRM Health is developing a novel type of therapeutics based on beneficial intestinal bacteria.

Universiteit Gent